Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
![Imatge de Publicacions](/sites/default/files/styles/3_1_small/public/2022-11/Portada_publicacions-petita_0.jpg?h=c6980913&itok=oZMso2V6)
PSGL-1 restricts HIV-1 infectivity by blocking virus particle attachment to target cells.
A Summary of the Fifth Annual Virology Education HIV Microbiome Workshop.
Correction to: Novel Approaches Towards a Functional Cure of HIV/AIDS.
Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain.
SARS-CoV-2 Consensus-Sequence and Matching Overlapping Peptides Design for COVID19 Immune Studies and Vaccine Development.
Network meta-analysis of post-exposure prophylaxis randomized clinical trials.
Gut T cell-independent IgA responses to commensal bacteria require engagement of the TACI receptor on B cells.
TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.
Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection.
TOX is expressed by exhausted and polyfunctional human effector memory CD8 + T cells